Alvarez-Erviti et al. investigated how exosome-mediated delivery of siRNAs to inhibit BACE1 expression could improve the neuropathological state in mice with Alzheimer's disease (AD) (80). This evidence concerns the gene BACE1 and Alzheimer disease.